#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chordoma Squamous cell carcinoma of the oral cavity Emphysema Scleroderma associated digital ulcer Pulmonary fibrosis Neuroendocrine carcinoma Liposarcoma Cervix carcinoma Hairy cell leukaemia Arteriosclerosis Urea cycle disorder Ependymoma Extra-osseous Ewing's sarcoma Kaposi's sarcoma Congenital growth hormone deficiency More trials…

    Learn about Rare Diseases

    Pulmonary fibrosis Sarcoma – Trials in Disease Chronic granulomatous disease – Trials in Disease Mucopolysaccharidosis III – Treatment Nodal marginal zone B-cell lymphoma – Diagnostics Sjogren’s syndrome Antisynthetase syndrome – Basic Information Hepatic angiosarcoma – Life with Disease Cerebral arteriovenous malformation haemorrhagic Glycogen storage disease type I – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Melphalan Perflutren Aon-D21 NADOFARAGENE FIRADENOVEC Voriconazole Nortriptyline Hydrochloride Timolol Insulin Lispro Hydrocortisone Acetate Gliclazide Poltreg-T1D Hyoscine Butylbromide Charcoal, Activated Iodixanol Testosterone Fipaxalparant Mva-209-Fsp-B1 Spartalizumab Briquilimab Pemigatinib More therapies…

    Learn about Your Condition

    Tonsillitis Hypothyroidism Infection Ewing's sarcoma Hereditary optic atrophy Fibrous dysplasia of bone Lung transplant rejection Apheresis Adenovirus infection Giant cell arteritis Atrial fibrillation Anal cancer Streptococcal infection Vitamin D deficiency Liposarcoma recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Pauls Stradins Clinical University Hospital

Pauls Stradins Clinical University Hospital

Pilsonu Iela 13, Riga, 1002, Latvia

Want to learn more about this study or check if you can participate? Contact us.

  • Study on CAL02 and Sodium Chloride for Patients with Severe Community-Acquired Bacterial Pneumonia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Cholesterol
    • Sphingomyelin (Egg)
    • Sodium Chloride
    Belgium Czechia France Greece Hungary Latvia +3

  • Evaluation of HLX10 Combined with Chemotherapy and Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized, Double-Blind Study

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Small cell lung cancer
    Austria Czechia Germany Greece Hungary Latvia +3

  • A study testing trimodulin in hospitalized adult patients with community-acquired pneumonia including COVID-19 pneumonia

    Not recruiting

    3 1
    Investigated Diseases:
    • Pneumonia
    • COVID-19
    Investigated Drugs:
    • Trimodulin (Human Igm, Iga, Igg Solution)
    Austria Belgium France Germany Hungary Latvia +3

  • A study comparing 4D-150 and aflibercept for adults with abnormal blood vessel growth in the eye due to age-related macular degeneration

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • ZUNIBERGENE ROCPARVOVEC
    • Aflibercept
    Bulgaria France Germany Hungary Italy Latvia +3

  • A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

    Not recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    • Chronic kidney disease
    Investigated Drugs:
    • Ziltivekimab
    Belgium Bulgaria Croatia Czechia Denmark Germany +12

  • A study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation

    Not recruiting

    3 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Ziltivekimab
    Austria Belgium Bulgaria Croatia Czechia Denmark +18

  • Study of efavaleukin alfa safety and effectiveness in adults with moderate to severe ulcerative colitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    Austria Belgium Bulgaria Czechia Denmark Finland +11

  • Study of Efavaleukin Alfa to Treat Adults with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    Austria Belgium Bulgaria Czechia Denmark Finland +11

  • Study of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)

    Not recruiting

    2 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Human Igg1 Kappa Monoclonal Antibody Against Crlf2
    Bulgaria Czechia Germany Hungary Ireland Latvia +5

  • Comparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Risankizumab
    • Vedolizumab
    Austria Bulgaria Croatia Czechia Estonia Finland +14
Previous Page
1 … 4 5 6 7 8 … 15
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!